Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Bof F, Maddalena G, Van K Morris II, Parseghian C, Higbie V, Eluri M, Morelli MP, YC Shen JP, Huey RW, Willis J, Kee BK, Haldar S, Martinez SA, Lonardi S, Bergamo F, Singh Raghav KP, Dasari A, Overman MJ, Kopetz S , Bent AH
Key Contraindications Wilsons disease: Individuals with this genetic disorder should strictly avoid GHK-Cu due to the risk of copper accumulation
If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
3rd & Brookeman, J
E.Koitka-WeberA.MattheusM.von EynattenM.et al (2017)
US$ 26.03
US$ 25.63
US$ 25.55
US$ 21.16
US$ 24.73
US$ 25.79
